Source: International Congress 2014 – Respiratory disease within hospital-based populations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wibberley, Y. Ochiai, R. Pitt, A. Mulgirigama (London, Berkshire, United Kingdom). IPF - The patients' differential diagnosis of COPD. Eur Respir J 2014; 44: Suppl. 58, 5000

Member's Comments

No comment yet.

Related content which might interest you: Alpha1-antytripsin deficiency in portuguese COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 Diagnosis confirmation and staging in patients hospitalized with diagnosis of COPD in a general hospital with adequate resources Source: Annual Congress 2013 –COPD treatment Year: 2013 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Defining asthma and COPD: differential diagnosis Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Efficacy of early COPD diagnosis and intervention system Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 COPD pulmonary rehabilitation - good enough for ILD patients? Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients Year: 2018 Study of IPF relatives as a method of early diagnosis of ILD disease Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016